PRM157 - THE IMPACT OF LANDMARK RESPONSE ON OVERALL SURVIVAL- IMPLICATIONS FOR THE ECONOMIC EVALUATION OF IMMUNE-THERAPY (I-O) TREATMENT IN SMALL CELL LUNG CANCER (SCLC)
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2277
https://www.valueinhealthjournal.com/article/S1098-3015(18)35579-7/fulltext
Section Title :
Section Order :
1635
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35579-7&doi=10.1016/j.jval.2018.09.2277